fig2
![Oncogenic Wnt3a: a promising specific biomarker in hepatocellular carcinoma](https://image.oaes.cc/94172bc2-47ab-429f-83e4-90b8864214f3/2659.fig.2.png)
Figure 2. Overall survival curves of Wnt5a or Wnt3a expression in HCC[20,65]. The hepatic Wnt5a or Wnt3a expression curves were calculated according to the Kaplan-Meier method. The accumulative survival curves of patients with HCC were made according to HCC tissues with low or high expression for Wnt5a or Wnt3a level (log-rank test, P < 0.001). (A) Wnt5a in HCC; (B) Wnt3a in HCC. HCC: hepatocellular carcinoma; Wnt3a: wingless-type MMTV integration site family member 3a; Wnt5a: wingless-type MMTV integration site family member 5a